3Eo Health Inc
CAGE Code: 94BR8
NCAGE Code: 94BR8
Status: Active
Type: Manufacturer
Summary
3Eo Health Inc is an Active Manufacturer with the Cage Code 94BR8.
Address
48 Dunham Ridge
Suite 4350
Beverly MA 01915-1844
United States
Points of Contact
- Telephone:
- 5083084805
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Krohne, Inc. Howe Tool Co Inc Accelerated Systems Inc Tren Engineering Corp Beverly Pattern Inc K M R Consultants Inc Golds Stationers Inc National Appliance Parts Seamark Corp Batrand David Construction Co Wind River Systems Gold Stationers Inc Beverly Instruments Co Inc Sensitech Inc Micromass Inc Colorcraft Sign Co Aulson Tanning Machinery Co Thermal Circuits Inc Yard Corp Audiophonics Corp
Frequently Asked Questions (FAQ) for CAGE 94BR8
- What is CAGE Code 94BR8?
- 94BR8 is the unique identifier used by NATO Organizations to reference the physical entity known as 3Eo Health Inc located at 48 Dunham Ridge, Suite 4350, Beverly MA 01915-1844, United States.
- Who is CAGE Code 94BR8?
- 94BR8 refers to 3Eo Health Inc located at 48 Dunham Ridge, Suite 4350, Beverly MA 01915-1844, United States.
- Where is CAGE Code 94BR8 Located?
- CAGE Code 94BR8 is located in Beverly, MA, USA.
Contracting History for CAGE 94BR8 Most Recent 25 Records
- 75A50122C00062
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- 15 Sep 2022
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00062
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- 14 Oct 2022
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00062
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- 22 Feb 2023
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00062
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- 25 Jul 2023
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50122C00062
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- 20 Sep 2023
- Developing A Sars-Cov-2 Molecular Diagnostic Assay With The Performance And Characteristics Necessary For Emergency Use Authorization (Eua)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)